Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sinocare Pays $273 Million for Nipro's US Diabetes Monitoring Business

publication date: Nov 3, 2015
Sinocare, a Changsha company that makes blood sugar sensing devices, will pay $273 million to acquire Nipro Diagnostics of Fort Lauderdale, Florida. Nipro makes glucose monitoring products for the US market and is a division of Nipro Industries, a Japanese medical equipment company. In the US, Nipro distributes its products under the True brand and also co-brands with retail outlets. Nipro Industries will continue to purchase diabetes products for distribution in some markets. More details....

Stock Symbol: (SHZ: 300298)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
San Francisco, USA
January 6, 2019
Use 'ChinaBio200' to get a USD200 Discount!
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China